Porphyria biomarker hunt could transform patient monitoring
NCT ID NCT02935400
First seen Jun 27, 2026 ยท Last updated Jun 27, 2026
Summary
This study aims to find new biological markers (biomarkers) that can show how active acute porphyria is in the body and how well treatments are working. Researchers will study 50 people with confirmed acute porphyria to measure gene activity related to heme production and stress responses. The goal is to gather early data to plan larger, more definitive studies that could improve diagnosis and care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE INTERMITTENT PORPHYRIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Texas Medical Branch
Galveston, Texas, 77555, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.